Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO
Craig brings nearly nine years of leadership experience to Volpara, where he has played a pivotal role in scaling the company from a startup to an industry leader in breast health solutions. Since joining Volpara in 2016, he has overseen financial operations, strategic acquisitions, and the company's transition to a SaaS-based model. Under his leadership as CFO from 2017 to 2024, Volpara's annual recurring revenue grew up to over
"We are confident that Craig's leadership will drive Volpara's continued success and innovation in breast health," said
"I am honored to step into this role and continue leading Volpara's mission to transform breast health through innovative AI-powered solutions," said Craig. "Having been part of Volpara's journey for nearly a decade, I look forward to working with our talented team, partners, and customers to expand our impact and drive even greater value in breast cancer detection and patient care."
Craig, who has worked across
About Lunit
Founded in 2013, Lunit (KRX:328130.KQ) is a medical AI company on a mission to conquer cancer. Lunit harnesses AI-powered medical image analytics and biomarker analysis to ensure accurate diagnosis and optimal treatment for each cancer patient. The FDA-cleared Lunit INSIGHT suite for cancer screening serves over 4,800 medical institutions across 55+ countries. Lunit clinical studies have been published in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. Headquartered in
About Volpara Health
Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. Used in over 3,500 facilities by more than 9,500 technologists worldwide. Volpara's software impacts nearly 18M patients, supports over 3.6M annual cancer risk assessments, and integrates seamlessly with electronic health records and imaging systems. Volpara helps radiologists quantify dense breast tissue with precision and technologists produce mammograms with optimal positioning, compression, and dose. Volpara software also streamlines operations to ease compliance and accreditation. Volpara, a Lunit company, is headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/lunit-announces-leadership-transition-at-volpara-craig-hadfield-appointed-ceo-302385666.html
SOURCE Lunit
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MegazoneCloud Selected as Amazon Quick SI Partner by AWS Generative AI Innovation Center
- New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration
- AEG Presents Enters Into Strategic Partnership With Creativeman Productions
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive Agreement, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share